News

Noting advances in hepatitis C treatment regimens, Walgreens expands access to its hepatitis C–focused patient care program.

According to a recent systematic review, the prescient and short-term use of NSAIDs and opioids with pharmacological sensitivity to an individual's comorbidities may result in pain relief, improved functioning, and reduced vocational and avocational absenteeism.

Bristol-Myers Squibb's investigational combination of daclatasvir and asunaprevir for type-1b hepatitis C virus infection has received breakthrough therapy designation by the FDA.

Deaths attributed to Alzheimer's disease dementia are much larger than what is reported on death certificates and may rival heart disease and cancer.

Aggressive medical therapy might be more closely linked to mortality and malignancy in pediatric inflammatory bowel disease than the condition itself, according to a new study.

Free birth control does not increase the likelihood of multiple sexual partners or promote risky behavior, according to a study published in Obstetrics & Gynecology.

Researchers have identified cannabinoid receptors in the region of the brain that regulates anxiety and the flight-or-fight response.

Atypical development in younger siblings of children with autism spectrum disorder can be detected as early as 12 months old.

After screening 1.2 million compounds, researchers found oxadiazole, a new class of non-β-lactam antibiotics, according to a study published in the Journal of the American Chemical Society.

Thrombosis significantly increases during pregnancy and again during the postpartum period until at least 12 weeks after delivery, according to new research.

Scientists have developed a nanofiber mesh they hope can be incorporated into a device to replace daily hospital visits for kidney failure patients.

Recent studies suggest that combination therapy with infliximab and azathioprine is more effective than monotherapy in patients with newly diagnosed Crohn's disease, but patients with more established Crohn's disease do not derive any extra benefit from triple therapy with infliximab, methotrexate, and prednisone compared to double therapy with infliximab and prednisone.

About 1% of the Alzheimer's disease population is infected by the genetic form of the illness, but biomarkers in the brain may be able to predict when patients' symptoms begin.

Researchers in Japan have developed a method to slow growth in bacteria that causes pneumonia in hospitalized patients with low immunity and is resistant to antibiotics.

Researchers concluded that blood sampling analysis as the only method of diagnosis for hypogonadism is leading to under- and overdiagnosis of low-T.

Cutaneous reactions occurred in most participants in a Netherlands-based multiple sclerosis therapy study, lowering dermatologic-specific quality-of-life scores.

In addition to its recognized anti-inflammatory effects, dimethyl fumarate also produces antioxidative effects that may be neuroprotective.

Using erythropoietin (EPO) therapy in patients with cardio-renal-anemia syndrome may be associated with more harm than benefit in this population. As new study found a statistically higher mortality rate among EPO users.

Minimally invasive surgical technique for patients with atrial fibrillation who cannot tolerate standard anticoagulant therapy uses sutures to tie off the left atrial appendage and offers increased stroke protection.

Researchers engineered an intravaginal device that will act as not only a contraceptive but also protect against HIV and herpes, according to a write up in PLOS ONE.

For patients receiving non-cardiac surgery, a study published in JAMA Surgery discovered that patients who experienced postoperative complications were more likely to be readmitted within 30 days.

Stressing the significant effect heart failure has on quality of life, a study published in Heart found that patients' and their families' lack of knowledge on their condition causes delays in seeking medical attention and an absence of a long-term care plan.

To curb the symptoms associated with Kawasaki Disease, researchers are recommended use of the drug infliximab, according to a study published online in the February 24 issue of The Lancet.

The implementation of DSM-5 criteria will result in a decrease of autism spectrum disorder diagnoses, according to a meta-analysis published in the February issue of the Journal of Autism and Developmental Disorders.

The US Food and Drug Administration (FDA) approved Myalept, a drug form of the hormone leptin, for the treatment of lipodystrophy.

Scientists from the University of Rostock in Germany explored the range of multiple sclerosis treatment options and examined them for possible infectious outcomes, side effects, and potential fatalities.

After concluding a Doribax (dorpenem) study early, the FDA announced the drug will undergo label changes to reflect increased risk of death for ventilator-associated pneumonia patients.

Aveed (testosterone undecanoate), an injection drug designed to combat hypogonadism, has been approved by the FDA after being rejected 3 times.

Multiple sclerosis is considered to be caused by deterioration of white matter in the brain, but a meta-analysis of recent studies concluded that grey matter atrophy could also be a factor.

Although less than 2.4% of end-stage renal disease patients are expected to experience renal recovery, a research team found sustained recovery occurs more often than previously believed.